Earnings News & Analysis
50 articles
Market Mood
Nvidia (NVDA) announces dividend hike, indicating potential for growth
Nvidia (NVDA) has recently increased its dividend, suggesting a commitment to returning value to shareholders. This rise in payouts may influence other companies within the technology sector to follow suit. The decision is expected to have a positive impact on investor sentiment and could potentially lead to higher stock prices across the market. The news highlights the growing trend of companies prioritizing shareholder returns amidst strong earnings performances.
Read More
Broadcom (AVGO) Earnings Impact on Chip Industry Rally
Broadcom (AVGO) reported earnings that may positively influence the semiconductor sector. Although specific earnings figures are not disclosed in the excerpt, the report suggests optimism around chip demand. Broadcom's performance has implications for market sentiment in tech, particularly as chipmakers are poised for recovery. The potential revival in chip stocks could serve to lift broader market indices linked to tech investments.
Read More
Kraft Heinz (KHC) CEO Anticipates Innovation Boost Next Year
Kraft Heinz CEO indicated plans to enhance innovation efforts in the upcoming year. This strategy could potentially improve product offerings, which might impact sales positively. The company's commitment to innovation is seen as critical for maintaining competitive advantage in the food industry. Enhanced product lines could play a significant role in growth amidst a challenging market environment.
Read More
First Majestic Silver (AG) Reports Record Q1 2026 Revenue Growth
First Majestic Silver (AG) reported a record Q1 2026 revenue of $477 million, a 95% increase year-over-year. Production rose by 96% following the acquisition of Gatos Silver in January 2025. The average realized silver price reached $86.35 per ounce, with operating margins expanding from $13 to $52 per ounce. The stock closed at $19.45 on May 22, 2026, reflecting a 232.03% gain over the past year, despite a recent 6.9% decline.
Read More
GameStop (GME) Announces $2 Billion Buyback and Revenue Growth
GameStop (GME) reported a 14% increase in quarterly revenue and announced a $2 billion share buyback program. This announcement follows a significant selloff related to events at eBay. The buyback aims to enhance shareholder value by reducing the total shares outstanding. GameStop's recent financial performance signals a potential recovery amid a challenging market environment.
Read More
Senior Loan ETFs BKLN, SRLN Offer $35,000 Annual Income
A $500,000 position in senior loan ETFs like BKLN and SRLN generates $35,000 annually at a 7% yield. As the Federal Funds target rate approaches 4%, these floating-rate funds adjust upwards, potentially increasing income. Comparatively, a $1,000,000 dividend growth portfolio starting at a 3.5% yield could reach $70,000 in annual income by year 10. The Invesco Senior Loan ETF (BKLN) has $7.15 billion in net assets, offering diversification across over 200 issuers, while both BKLN and SRLN returned approximately 5% over the past year.
Read More
Macy's (M) Reports 3% Q1 Comparable Sales Growth, Raises Guidance
Macy's (M) announced a 3% overall increase in comparable sales for Q1, attributed to the upgrade of 200 reimagined stores. Bloomingdale's saw a notable 10.2% growth in comparable sales. The company now forecasts net sales for 2026 between $21.5 billion and $21.75 billion, exceeding the previous estimate of $21.59 billion. Adjusted earnings per share guidance has been raised to a range of $2 to $2.20, reflecting better-than-expected sales and consumer behavior trends amid macroeconomic uncertainty.
Read More
Dividend Portfolio Return: $43,770 Annual Income and $7,515 Tax Impact
A $1 million dividend portfolio generates approximately $43,770 annually, subjected to $7,515 in taxes at the 24% bracket. This portfolio includes holdings such as Realty Income (O), Schwab U.S. Dividend Equity ETF (SCHD), and Johnson & Johnson (JNJ). The taxable portion of income is divided into qualified and ordinary income, impacting the total tax liability. The advantage of using a Roth IRA allows the full income to remain untaxed, highlighting the significance of account placement for tax efficiency.
Read More
Higher Rates Projected to Benefit JPMorgan (JPM) Net Interest Income by 8%
Between 2008 and 2022, U.S. banks struggled with near-zero interest rates, impacting earnings. The Federal Reserve currently has the federal funds rate in the range of 3.50% to 3.75%, with expectations for a rate hike early next year. JPMorgan Chase (JPM) reported guidance for $103 billion in net interest income (NII) for the full year, representing an increase of nearly 8% from last year. The current yield curve, while previously inverted, is starting to steepen, which could positively impact bank profitability.
Read More
GitLab (GTLB) Stock Price Target Raised After Solid Q3 Results
Cantor Fitzgerald has raised its price target for GitLab (GTLB) following the company's solid quarterly results. This shift in target reflects the positive performance in GitLab’s financial metrics, contributing to a more favorable outlook in the market. Enhanced earnings projections and revenue growth are essential for potential investors and may lead to increased trading volumes. GitLab's ability to maintain upward momentum in performance metrics can impact its valuation and overall market presence significantly.
Read More
Cognyte Software (CGNT) Earnings Miss by $0.05, Revenue Above Estimates
Cognyte Software (CGNT) reported earnings that missed expectations by $0.05. However, the company's revenue exceeded estimates, indicating stronger than anticipated market performance. Revenue figures were not specified in the article, but exceeding estimates suggests positive demand. This mixed earnings report could have varying impacts on market perceptions of CGNT moving forward, especially in the context of sector performance.
Read More
Legend Biotech (LEGN) Stock Price Target Raised by UBS on NHL Outlook
UBS increased its price target for Legend Biotech (LEGN) reflecting a positive outlook on its NHL therapy development. No specific new price target was provided in the report. The adjustment signifies UBS's confidence in the market potential of LEGN's therapeutic advancements and could influence investor sentiment positively. This change might impact trading volumes as investors react to the report, indicating potential shifts in the stock's market dynamics.
Read More
Bayer (BAYRY) Confirms No Restructuring Plans Amid Litigation
Bayer (BAYRY) announced that it has no plans to restructure its operations despite facing ongoing litigation threats. The company aims to maintain its current structure while addressing legal challenges related to product liabilities. This statement implies that Bayer is confident in its existing strategy and operations. The decision could affect investor perception and may influence trading volumes in the related sectors as legal uncertainties often impact stock performance.
Read More
Palo Alto (PANW) Updates Price Target Following Strong Earnings Report
Palo Alto Networks (PANW) has increased its price target following reported strong earnings. This positive development comes amid previous concerns regarding potential disruptions caused by AI in cybersecurity. The company's performance indicates resilience and may influence investor confidence. Strengthening earnings can lead to upward adjustments in market valuations and investor interest in the cybersecurity sector.
Read More
GameStop (GME) Reports Higher Profit with $2 Billion Buyback Program
GameStop (GME) announced an increase in profits and the initiation of a $2 billion stock buyback program. This strategic move aims to enhance shareholder value and indicates the company's confidence in its financial health. Market analysts may view this positive profit trend as a potential catalyst for increased investor interest and stock price appreciation. The buyback reflects GameStop's ongoing efforts to improve its capital structure and return capital to shareholders.
Read More
Victoria's Secret (VSCO) Stock Surges 47% for Record Trading Day
Victoria's Secret (VSCO) experienced a significant stock increase of 47% on Tuesday, marking its best trading day to date. This surge indicates positive market reception, attributed to improved product offerings in their lingerie line. Such a rise in shares could imply strengthened investor confidence in the company's ability to innovate and connect with consumers. Overall, this growth may impact the company's market valuation and future trading volumes positively.
Read More
Hewlett Packard Enterprise (HPE) Earnings Beat Estimates, Up 24.3%
Hewlett Packard Enterprise (HPE) reported earnings of $0.79 per share on $10.7 billion in sales, exceeding analyst expectations of $0.53 per share on $9.8 billion. This led to a stock price increase of 24.3% through 10 a.m. ET. HPE also raised its fiscal Q3 guidance, projecting sales of $11.5 billion to $12.1 billion and full-year sales ranging from $44.2 billion to $45.6 billion, indicating potential growth of 29% to 33%. The company's gross profit margins rose 8 percentage points to 36.5%, and it generated $900 million in free cash flow compared to a loss last year.
Read More
Victoria's Secret (VSCO) Earnings Beat Guides Sales Up 40% Forecast
Victoria's Secret (VSCO) shares increased by 40% in premarket trading after the company exceeded earnings expectations in its fiscal first quarter. The company raised its full-year sales forecast to between $7.03 billion and $7.13 billion, surpassing prior estimates of $6.85 billion to $6.95 billion. Adjusted operating income guidance was also lifted to between $550 million and $580 million from $430 million to $460 million. This upward revision follows strong sales performance, including a notable gain in market share among younger consumers and lower tariff costs.
Read More
Paragon Banking (PAG) Reports Higher Impairment Charges Impacting Profit
Paragon Banking (PAG) experienced a decline in half-year profit due to increased impairment charges. The charges significantly affected the company's financial performance, leading to a notable financial impact on its earnings. This situation may influence investor sentiment and trading activity for PAG going forward. Tracking these changes is essential for comprehending the bank's future market strategies and impact on stock performance.
Read More
Abivax (ABVX) Shares Drop 32% After Ulcerative Colitis Drug Update
Shares of Abivax (ABVX) declined as much as 32% following a report on its drug for ulcerative colitis, which met clinically meaningful efficacy and a remission rate of approximately 40%. Despite achieving key endpoints, the trial revealed cancer cases in patients taking higher doses. Investigators deemed these cases unrelated to the treatment, although analysts note the results complicate the drug's prospects. This downturn follows a nearly 1,700% increase in stock value in 2025, and the company is also seen as a potential takeover target in the biotech sector.
Read More
Amazon (AMZN) Prime Day Scheduled June 23-26 Amid Inflation Concerns
Amazon's (AMZN) Prime Day event will run from June 23 to June 26 this year. This four-day shopping event aims to attract new members to its $139 annual loyalty program. Limited-time deals will include groceries and household essentials, with prices starting as low as $1. However, U.S. consumer sentiment fell to a record low in May, attributed to high prices and economic uncertainty, which could impact shopping behavior during the event.
Read More
Red Violet (RDVT) Files Form 13D/A on June 1 Revealing Changes
Red Violet (RDVT) submitted its Form 13D/A on June 1 detailing significant ownership changes. The filing indicated that certain beneficial owners now hold a combined total of 12% of RDVT's outstanding shares. This update is vital as it reflects shifts in shareholder composition which may affect future corporate governance and market perceptions. Increased shareholder stakes often lead to enhanced engagement between management and investors, potentially influencing the company's strategic direction.
Read More
Hewlett Packard Enterprise (HPE) Shares Surge 26% After Earnings
Hewlett Packard Enterprise (HPE) shares rose 26% after the company raised its revenue guidance and reported its largest earnings beat since 2018. The S&P 500 gained 0.26% and the Nasdaq Composite increased by 0.42%, both closing at new record highs. Futures for the S&P 500 and Nasdaq 100 slipped 0.2% and 0.3%, respectively, while Dow futures fell by 122 points, or 0.2%. Recent market enthusiasm, particularly in the tech sector driven by Nvidia's new chip launch, contributed to positive market momentum.
Read More
Syndax Pharmaceuticals Inc (SNDX) Files Form 144 on June 1
Syndax Pharmaceuticals Inc (SNDX) submitted Form 144 on June 1. This filing indicates the potential sale of shares, typically performed by insiders or affiliates. Such filings can affect investor perception, as they may suggest insider selling, which can influence market behavior. The document's specifics and the number of shares registered have not been disclosed, making it difficult to ascertain the immediate impact on SNDX stock prices.
Read More
Veracyte (VCYT) stock target raised to $57 based on trial data
Needham has increased the stock price target for Veracyte (VCYT) to $57 following positive trial data. This adjustment reflects the market's response to the performance indicators demonstrated in the trials, suggesting potential for growth in asset prices. Investors and analysts may interpret this upward revision as a signal of confidence in VCYT's future developments. The new target offers a benchmark for evaluating VCYT's stock performance going forward.
Read More
Ralph Lauren (RL) Stock Shows Limited 4% Gain in 2026
In 2025, Ralph Lauren (RL) shares rose over 50%, but in 2026, the gain has been reduced to 4%. Currently trading in the mid-$360s, RL is positioned for a tighter trading range. Investors can implement a short strangle strategy, selling the June 18th 330 put and 390 call for approximately $6.00 in premium, defining a range of $324–$396. Despite some resilience, macro headwinds like tariff uncertainty and cautious consumer behavior limit upside potential in the near term.
Read More
Strategy (MSTR) Shares Drop 5.3% Following $2.5 Million Bitcoin Sale
Strategy (MSTR) reported a 5.3% decline in its stock price, dropping to $150.68 after disclosing the sale of 32 Bitcoin for $2.5 million. This represented 0.0038% of the firm’s total Bitcoin holdings of 843,706 BTC, valued at approximately $60 billion. Despite this move, the company's executive chairman emphasized the focus on its product STRC, which has a substantial monthly cost of about $100 million. The market reacted strongly, reflecting concerns over operational strategies amid dividend payouts and future Bitcoin sales.
Read More
Virtus Private Credit ETF Form 6K Released on June 1
Virtus Private Credit ETF filed a Form 6K on June 1. The filing is a standard requirement that informs investors about significant changes or events related to the ETF. Such disclosures are essential for maintaining transparency and compliance in financial markets. The content of this filing has not been detailed in this summary, but it may impact investor confidence and trading strategies related to the ETF in the future.
Read More
Cogent (COGT) Stock Rating Reiterated by H.C. Wainwright After Trials
H.C. Wainwright has reiterated its stock rating on Cogent (COGT) following the company's recent trial results. This decision reinforces the analyst's confidence in the company's ongoing developments. The report indicated that Cogent is continuing its efforts in strategic initiatives that may affect future performance. Market reactions may depend on how investors perceive the implications of these trial outcomes and future revenue projections.
Read More
Ionis (IONS) Stock Rating Reiterated on Hepatitis B Data
H.C. Wainwright has reiterated its rating on Ionis Pharmaceuticals (IONS) based on recent data concerning hepatitis B treatment. While specific figures or numerical data from the report have not been disclosed, Wainwright's endorsement suggests sustained confidence in IONS's pipeline developments. The implications of such ratings often influence investor sentiment and trading patterns. Therefore, this reaffirmed stance may contribute to fluctuations in IONS's market performance as investors respond to the potential for new treatments.
Read More
TiumBio (TMB) Reports Trial Data for Head and Neck Cancer Drug
TiumBio (TMB) has released results from clinical trials concerning its head and neck cancer drug. The trials have shown promising efficacy rates, but specific numbers and other key data points were not disclosed in the announcement. This development could influence investor confidence in TiumBio's pipeline and market position within the oncology sector. Market analysts will be monitoring the reaction of TiumBio's stock as additional details become available regarding regulatory submissions or partnerships.
Read More
Dell (DELL) Shares Surge 32.76% After Impressive Q1 FY27 Earnings
Dell Technologies (DELL) reported first-quarter fiscal 2027 earnings with record revenue of $43.8 billion, marking an 88% increase year-over-year. The diluted EPS reached $5.24, a 282% rise from the previous year. Following the earnings announcement, Morgan Stanley acknowledged its previous Underweight rating and price target of $170 is now under review. The stock surged 32.76% on May 29, closing at $420.91, contributing to a year-to-date increase of 236.88%. Dell's full-year guidance was also raised to a midpoint of $167 billion in revenue, up nearly 50% from previous projections.
Read More
Super Micro Computer (SMCI) Stock Surge Driven by Revenue Growth
Super Micro Computer (SMCI) shares increased significantly this week following a reported revenue growth of 85% year-over-year for the fiscal first quarter. The company posted revenue of $1.47 billion compared to $793 million in the same quarter last year. Additionally, SMCI's net income rose to $183 million, up from $53 million a year prior. This exceptional financial performance is anticipated to boost market confidence and investor interest in SMCI shares moving forward.
Read More
Analog Devices Inc (ADI) Sees 37% YoY Revenue Growth, Price Target Raised
Analog Devices Inc (ADI) reported fiscal Q2 2026 revenue of $3.62 billion, exceeding analysts' expectations of $3.50 billion, representing a 37% year-over-year increase. Adjusted EPS rose to $3.09 from $1.85 a year ago, surpassing the consensus estimate of $2.92. On May 26, Argus increased its price target for ADI shares to $460, up from $400, maintaining a Buy rating. The growth was driven by strong performance in communications and industrial sectors, with sales in three of ADI's four end markets showing double-digit percentage increases.
Read More
Quanta Services (PWR) Reports Record Backlog of $48.5 Billion
Quanta Services (PWR) announced a record backlog of $48.5 billion at the end of Q1, a 37.5% increase year-over-year. The company’s 12-month backlog also rose by 45%, equating to its full-year 2025 revenue. The shift towards larger fixed-price contracts, comprising 63% of total revenue, is expected to enhance margin potential. Additionally, adjusted EBITDA increased by 36% in the quarter, with operating margins improving to 8.7%. These trends indicate strong demand and operational efficiency but suggest a need to monitor valuation due to growth pressures.
Read More
Zscaler (ZS) Stock Drops 18.3% Following Q3 2026 Results Release
Zscaler (ZS) stock experienced an 18.3% decline after releasing its fiscal Q3 2026 results, despite reporting a non-GAAP profit of $1.08 per share and sales of $850.48 million, which surpassed Wall Street estimates. Year-over-year sales growth was 25.4%, exceeding projections by $14.82 million. Zscaler raised its full-year sales and annual recurring revenue (ARR) targets, increasing the ARR estimate to between $3.740 billion and $3.749 billion. However, management expects a deceleration in growth rates for fiscal 2027, predicting ARR and revenue growth between 16% and 17%.
Read More
United Rentals (URI) Growth and Market Resilience Insights
United Rentals (URI) has consistently demonstrated strong performance, with notable rental revenue growth reported at 17% year-over-year. The company focuses on expanding its fleet and investing in technology to enhance operational efficiency. In the previous quarter, URI reported a P/E ratio of 20.4, indicating solid market confidence in future earnings growth. As the construction sector shows signs of recovery, URI's strategic plans position it well to capitalize on upcoming market opportunities.
Read More
New Oriental Education (EDU) Reports $1.42 Billion Revenue Growth
Cederberg Capital sold 826,670 shares of New Oriental Education (EDU), reducing its position by $45 million in Q1 2026. New Oriental Education reported a revenue of $1.42 billion for the third quarter, representing a 20% year-over-year increase. The company's operating income increased by 45% to $180 million, and net income rose by 45% to $127 million. As of the latest trading session, EDU shares were priced at $45.79, reflecting a 3% decline over the past year, in contrast to a 28% increase in the S&P 500.
Read More
Bravo Brio (BRIO) Files Second Chapter 11 Bankruptcy in 2025
Bravo Brio Restaurant Group filed for Chapter 11 bankruptcy for the second time in August 2025 in Florida, following earlier struggles that led to the company operating 38 total restaurants, down from a peak of 130. The chain, which competes with Olive Garden (DRI), cited economic pressures, including inflation and rising costs, as significant factors impacting performance. The company aims to restructure by closing underperforming locations and cutting costs. As reported, the brand currently has 19 remaining locations each for its Bravo and Brio names across 10 states.
Read More
Micron Technology (MU) Set for June Earnings Boost Amid 208% Growth
Micron Technology (MU) stock has risen by 208% in 2026, with fiscal Q3 results expected on June 24. Revenue estimates foresee a 261% increase, accompanied by a 10x boost in earnings. The favorable conditions in the memory market, particularly due to demand from AI data centers, are anticipated to drive this performance. Ciena (CIEN) also reports on June 4, with shares rising 136% in 2026, benefiting from increased demand for optical networking components in the AI sector, as the global data center interconnect market is projected to grow substantially.
Read More
Invest $40,000 to Generate $4,800 in Annual Income from Stocks
To achieve $4,800 in annual passive income, an investment of $40,000 would require a blended yield of 12%. This yield is double that of mature dividend payers such as Altria (MO) with a 5.7% yield, Verizon (VZ) at 5.9%, and Main Street Capital (MAIN) yielding 8.7%. Currently, a diversified portfolio split three ways would provide approximately $2,700 annually, leading to a blended yield of about 7%. The article discusses the discrepancies between expected yields and actual returns in the income stock market.
Read More
Pfizer (PFE) Stock Price Drops Over 50% Since Pandemic Peak
Pfizer (PFE) has experienced a stock price decline of over 50% since its peak during the COVID-19 pandemic. This significant drop is attributed to market adjustments after expectations of ongoing vaccine needs did not materialize, leading to decreased investor confidence. Additionally, Pfizer faces challenges with upcoming patent expirations through 2028 and has struggled to develop new drugs to replace those losing patent protection. The company’s recent decision to acquire a competitor with a promising GLP-1 drug may impact future growth prospects.
Read More
Cameco Stock (CCJ) Investment Reasons Amid Market Insights
The article discusses three reasons why investors should consider buying Cameco (CCJ) stock. These reasons revolve around the company's potential to benefit from rising uranium prices and growing global demand for nuclear energy. The current trading volume for Cameco shares has shown an increase, reflecting heightened interest among investors. Additionally, analysts suggest that ongoing geopolitical tensions may further support uranium pricing, potentially impacting market dynamics positively for CCJ.
Read More
Bank of America (BAC) Q2 Trading Revenue to Increase 15% Reported
Bank of America (BAC) projects a 15% increase in trading revenue for the second quarter, as reported by Reuters. This anticipated rise reflects the bank's strong positioning in the trading sector and may impact overall market sentiment. A positive outcome could contribute to improved financial performance for BAC, potentially influencing investor confidence. Trading revenue dynamics are crucial to understanding profitability and market positioning for banks like BAC.
Read More
Cigna (CI) Downgraded by Barclays, Price Target Cut to $304
On May 26, Barclays downgraded Cigna (CI) from Overweight to Equal Weight and reduced its price target from $310 to $304. The downgrade reflects concerns around Cigna's limited earnings upside potential due to its lower exposure to government insurance programs, alongside uncertainties regarding a pharmacy benefit manager transition. Additionally, Barclays highlighted risks related to commercial membership losses and potential job cuts related to AI. This situation contrasts with UBS's recent rating increase, raising Cigna's target to $400, indicating differing outlooks among analysts.
Read More
Liberty Capital Corporation (GLIBA) Identified for Low P/E Ratios
Liberty Capital Corporation (GLIBA) has been explored as a potential growth stock with a low price-to-earnings (P/E) ratio. Investors often seek such stocks for their growth potential at reasonable valuations. The P/E ratio serves as an important metric in evaluating a company's market value relative to its earnings, indicating the investor sentiment about its growth prospects. Identifying and investing in such equities may enhance portfolio diversification and returns.
Read More
Novartis (NVS) Radiopharma Drug Shows Promise in Early Study
An early study on a radiopharmaceutical drug developed by Novartis (NVS) has shown promising results. The specifics of the trial, including patient outcomes or response rates, were not disclosed in the report. The potential success of this drug could impact Novartis' market position in the pharmaceuticals sector. Investors may want to monitor further developments in clinical trials which could affect stock performance.
Read More
LITE Hedge Fund Stake Reduced, Revenue Misses Consensus by $12M
In the first quarter of 2026, Leopold Aschenbrenner's hedge fund sold its stake in Lumentum Holdings Inc. (LITE), previously holding 1.3 million shares in Q4 2025. Lumentum reported net revenue of $808.4 million for Q3 FY2026, a 90% year-over-year increase, but fell short of the consensus expectation of $820.4 million by approximately $12 million. While shares have increased around 170% over six months, concerns arise as the company faces a potential growth ceiling. Additionally, Lumentum's trailing five-year earnings have decreased by 33.1% annually, indicating inherent volatility in business performance.
Read More
HIVE (NASDAQ:HIVE) 13F Stake of 3.4 Million Shares Announced
Situational Awareness LP has established a new stake in HIVE Digital Technologies Ltd. (NASDAQ:HIVE) consisting of approximately 3.4 million shares as per their 13F filing for Q1 2026. The company is involved in building and operating data centers using green energy, as well as cryptocurrency mining and blockchain solutions. Recently, HIVE initiated a 320 MW Sovereign AI Infrastructure project in the Greater Toronto Area, with a target for $225 million in Annual Recurring Revenue from high-performance computing operations. This strategic move may impact investor sentiment due to the company's focus on stable revenue streams and expanding AI capabilities.
Read More
Pfizer (PFE) Analysts Show Caution Amid 50% Stock Decline
Currently, only 2 out of 29 analysts rate Pfizer (PFE) as strong buy, while over 60% suggest a cautious outlook with ratings of hold, underperform, or sell. The stock has declined more than 50% from its 2021 peak. Patent expirations for key drugs like Eliquis and Vyndaqel are expected to impact revenues significantly by 2028. Despite these challenges, Pfizer maintains a dividend yield of 6.6%, much higher than the market average of 1.1%. The company continues efforts in drug development, including acquiring a promising GLP-1 candidate after dropping its own.
Read More